skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.12d (Release date: 2017-12-26)
SearchBox Top
SearchBox Bottom
Nabiximols (Code C71037)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Nabiximols

Definition: An herbal preparation containing a defined quantity of specific cannabinoids formulated for oromucosal spray administration with potential analgesic activity. Nabiximols contains a standardized extract of tetrahydrocannabinol (THC), the non-psychoactive cannabinoid cannabidiol (CBD), other minor cannabinoids, flavonoids, and terpenes from two cannabis plant varieties. Cannabinoids interact with G protein-coupled cannabinoid 1 (CB1) receptors in the central nervous system, resulting in analgesic, euphoric, and anticonvulsive effects.

Display Name: Nabiximols

Label: Nabiximols

NCI Thesaurus Code: C71037 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C2347556  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Cannabidiol mixture with Tetrahydrocannabinol
Cannabis-Based Oromucosal Spray GW-1000-02
THC and CBD Mixture

External Source Codes: 
CAS Registry Number 56575-23-6 (see NLM ChemIDplus info)
PDQ Closed Trial Search ID 572214
PDQ Open Trial Search ID 572214 (check for NCI PDQ open clinical trial info)
UMLS CUI C2347556

Other Properties:
     Name Value (qualifiers indented underneath)
code C71037
Contributing_Source CTRP
Legacy_Concept_Name Cannabis-Based_Oromucosal_Spray_GW-1000-02
Semantic_Type Organic Chemical
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom